Stock Ticker

  • Loading stock data...

pSivida Corp. (NASDAQ:PSDV) Elects Veteran Healthcare Executive To Its Board

pSivida Corp. (NASDAQ:PSDV) reported that it has elected Kristine Peterson, who is a seasoned healthcare executive, to its Board of Directors. Peterson has extensive pharma experience, having worked as the CEO of Valeritas from 2009 to 2016, a commercial-stage medical technology firm focused on simplifying life and improving health for people with diabetes. She has […]

3D Printing Technology May Not Be Common, But It will Get A New Face

The use of 3D printing technology is no longer common perhaps as a result of its high cost and slow pace. In fact, a lot of companies that have invested in it have hit real blocks including lack of manufacturing expertise which is very prevalent. But apparently, many people are interested in the technology according […]

Johnson & Johnson (NYSE:JNJ) To Revive Its Non-Prescription Medicines Business

Johnson & Johnson (NYSE:JNJ) might successfully reopen its Non-prescription medicines business that was shut down initially due to recalls. Over the past few years, the business suffered due to numerous recalls for some of its products. The company called back more than 135 million medicine bottles after tiny chunks of metal was discovered in Tylenol, […]

Galapagos NV (ADR) (NASDAQ:GLPG) Raises IPO Stakes And Gets Positive Response

Galapagos NV (ADR) (NASDAQ:GLPG) has raised the initial public offering (IPO) stake of around $290 or €258 million, and the results seem to have been positive. The first trading day at Nasdaq helped the shares grow by 20.10%. According to the company Founder and CEO Onno van de Stolpe was very happy to be on […]

Johnson & Johnson (NYSE:JNJ) And Actavis plc (NYSE:ACT) Cleared Of Painkillers Addiction Allegations

Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to […]

International Business Machines Corp. (NYSE:IBM) Clinches Digital Health Deal With Apple Inc. (NASDAQ:AAPL), Medtronic PLC (NYSE:MDT) And Johnson & Johnson (NYSE:JNJ)

International Business Machines Corp. (NYSE:IBM) has established partnerships with Apple Inc. (NASDAQ:AAPL) and the world’s largest medical devices producers to deliver health data from Apple Watches to doctors and insurers. Another major goal is to craft personalized treatments for hip replacement patients and diabetics. IBM’s foray into digital healthcare will empower users monitoring their heart […]

Johnson & Johnson (NYSE:JNJ) CEO Alex Gorsky Attributes 3Q Results To Continued Success Of New Products And Strength In Core Business

Boston, MA 10/15/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) Chairman and CEO Alex Gorsky, said that its third-quarter financial results reflected the continued success of new products and the strength of core business. He also said that the company was making conscious choice of portfolio thereby positioning itself to achieve its short-term, as well as, […]

Trade Update: Marriott Vacations Worldwide Corp (NYSE:VAC); UTStarcom Holdings Corp (NASDAQ:UTSI); Johnson & Johnson (NYSE:JNJ)

Boston, MA 10/13/2014 (wallstreetpr) – Marriott Vacations Worldwide Corp (NYSE:VAC) announced on 10th October that it has completed the securitization of nearly “$250 million of vacation ownership loans”. The deal involved MVW Owner Trust buying nearly $205 million of the vacation loans on 9th October. It also retains an option to buy the reminder of […]

Boston Scientific Corporation (NYSE:BSX) Gets Part Relief From Court On Mesh Punitive Damages

Boston, MA 10/06/2014 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) could derive some solace from a District Court order. The court has slashed the punitive damages to less than half in the case filed by women on the company’s vaginal mesh implants. Reduced Damages In the third trial heard on the company’s product, a Texas Judge reduced […]

Inovio Pharmaceuticals Inc (NASDAQ:INO) To Advance Development Of Ebola Vaccine To Human Trials

Boston, MA 09/25/2014 (wallstreetpr) – Inovio Pharmaceuticals Inc (NASDAQ:INO) and Seoul-based GeneOne Life Science Inc (KRX:011000) have announced plans to conduct human trial on Ebola vaccine by 2015. Inovio and GeneOne have advanced to the next level with their Ebola treating DNA vaccine and are seeking to start human trails by the next year. The two […]

Johnson & Johnson (NYSE:JNJ) Could Fetch Up To $2 Billion From Cordis Sale

Boston, MA 09/02/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ) plans to sell its medical devices business that makes items such as stents and catheters, stated Wall Street Journal in a recent article. The sale of the unit is expected to help JNJ further the slimming process of its wide-raging business portfolio. Sources said the sale […]

The Procter & Gamble Company (NYSE:PG): Probable Candidates for the CEO Post

Boston, MA 08/25/2014 (wallstreetpr) – Consumer packaged goods company, The Procter & Gamble Company (NYSE:PG), has been on a transition ever since current CEO, Allan G. Lafley, returned from retirement mandated with the responsibility of restoring the company’s growth metrics that was apparently stagnating according to USA Today. Since his return, Lafley has made management […]

Pfizer Inc. (NYSE:PFE) And Bristol-Myers Squibb Co (NYSE:BMY) Announced FDA Clearance For Eliquis For Blood Clots Treatment

Boston, MA 08/22/2214 (wallstreetpr) – Pfizer Inc. (NYSE:PFE) and Bristol-Myers Squibb Co (NYSE:BMY) announced recently that the USFDA has given an extension of approving Eliquis, the blood thinner, which shall be used for the treatment of fatal blood clots. The treatment of two kinds of blood clots can be done by way of this blood […]

Johnson & Johnson (NYSE:JNJ) Acts Unconventionally, Will That Hurt Revenue?

Boston, MA 08/05/2014 (wallstreetpr) – Johnson & Johnson (NYSE:JNJ), a maker and seller of a wide range of products that serve the health care field, announced the withdrawal of one of its products that has apparently generated more heat than light in recent times. From the usefulness to the risks associated with its usage, medical professionals, […]

BIOLASE Inc (NASDAQ:BIOL) Management Changes Announcement Boosts Stock Price

Boston, MA 06/18/2014 (wallstreetpr) – Leading manufacturer and distributor of dental lasers, BIOLASE Inc (NASDAQ:BIOL) announced significant changes in the management with the objective of strengthening its leadership, global competitiveness, and its focus towards professional customers, as well as, their patients. The changes were made following the Delaware Supreme Court order on June 12 on […]

Sign Up To Get Our Latest Stocks Alerts